Bumrungrad Hospital Public Company Limited
BUGDFOTCHealthcare● Active
$4.75
+$0.00(+0.00%)
Market Cap$3.8B
P/E Ratio—
52W High$6.31
52W Low$3.95
Bumrungrad Hospital Public Company Limited (BUGDF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BUGDF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 21, 2026EPS Actual
$0.06
Est. $0.06 · -1.1%
Revenue
$0.19B
Est. $0.19B · +2.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 21, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
BUGDF reports quarterly as a OTC-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 14, 2026 | $0.06 | — | — | — | $0.19B | — |
| ▼ Q2 FY2026 | Apr 21, 2026 | $0.06 | $0.06 | -1.1% | $0.19B | $0.19B | +2.5% |
| ▲ Q1 FY2026 | Feb 17, 2026 | $0.07 | $0.09 | +20.4% | $0.21B | $0.21B | -1.5% |
| ▼ Q4 FY2025 | Nov 6, 2025 | $0.07 | $0.00 | -97.0% | $0.01B | $0.20B | -96.9% |
| ▲ Q3 FY2025 | Jul 31, 2025 | $0.06 | $0.07 | +2.1% | $0.19B | $0.20B | -9.2% |
| ▼ Q2 FY2025 | Apr 23, 2025 | $0.06 | $0.06 | -9.3% | $0.18B | $0.20B | -9.7% |
| — Q1 FY2025 | Feb 27, 2025 | $0.06 | $0.06 | +0.6% | $0.19B | $0.19B | +0.8% |
| ▼ Q4 FY2024 | Nov 7, 2024 | $0.08 | $0.07 | -12.3% | $0.19B | $0.22B | -12.9% |
Q3 FY2026
Aug 14, 2026
EPS Actual
—
EPS Est.
$0.06
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 21, 2026Miss
EPS Actual
$0.06
EPS Est.
$0.06
EPS Surpr.
-1.1%
Revenue
$0.19B
Q1 FY2026
Feb 17, 2026Beat
EPS Actual
$0.09
EPS Est.
$0.07
EPS Surpr.
+20.4%
Revenue
$0.21B
Q4 FY2025
Nov 6, 2025Miss
EPS Actual
$0.00
EPS Est.
$0.07
EPS Surpr.
-97.0%
Revenue
$0.01B
Q3 FY2025
Jul 31, 2025Beat
EPS Actual
$0.07
EPS Est.
$0.06
EPS Surpr.
+2.1%
Revenue
$0.19B
Q2 FY2025
Apr 23, 2025Miss
EPS Actual
$0.06
EPS Est.
$0.06
EPS Surpr.
-9.3%
Revenue
$0.18B
Q1 FY2025
Feb 27, 2025
EPS Actual
$0.06
EPS Est.
$0.06
EPS Surpr.
+0.6%
Revenue
$0.19B
Q4 FY2024
Nov 7, 2024Miss
EPS Actual
$0.07
EPS Est.
$0.08
EPS Surpr.
-12.3%
Revenue
$0.19B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $2.35 | $2.35 | $2.35 | 1 |
| Q4 FY2026 | $2.41 | $2.41 | $2.41 | 1 |
| Q3 FY2026 | $2.37 | $2.37 | $2.37 | 1 |
| Q2 FY2026 | $2.08 | $2.08 | $2.09 | 1 |
| Q1 FY2026 | $2.08 | $2.08 | $2.09 | 1 |
| Q4 FY2025 | $2.30 | $2.31 | $2.31 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $6.9B | $6.9B | $6.9B | 1 |
| Q4 FY2026 | $6.7B | $6.7B | $6.7B | 1 |
| Q3 FY2026 | $6.7B | $6.7B | $6.7B | 1 |
| Q2 FY2026 | $6.1B | $6.1B | $6.1B | 3 |
| Q1 FY2026 | $5.9B | $6.1B | $6.2B | 5 |
| Q4 FY2025 | $6.6B | $6.6B | $6.7B | 9 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 21, 2026 | -1.1% | $4.75 | $4.75 | +0.00% |
| ▲ Q1 FY2026 | Feb 17, 2026 | +20.4% | $4.75 | $4.75 | +0.00% |
| ▼ Q4 FY2025 | Nov 6, 2025 | -97.0% | $4.23 | $4.23 | +0.00% |
| ▲ Q3 FY2025 | Jul 31, 2025 | +2.1% | $4.23 | $4.23 | +0.00% |
| ▼ Q2 FY2025 | Apr 23, 2025 | -9.3% | $6.31 | $6.31 | +0.00% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +0.6% | $6.31 | $6.31 | +0.00% |
| ▼ Q4 FY2024 | Nov 7, 2024 | -12.3% | $7.91 | $7.91 | +0.00% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +0.2% | $6.40 | $6.40 | +0.00% |
Q2 FY2026+0.00%
Report Date
Apr 21, 2026
EPS Beat/Miss
-1.1%
Price Before
$4.75
Price After
$4.75
Q1 FY2026+0.00%
Report Date
Feb 17, 2026
EPS Beat/Miss
+20.4%
Price Before
$4.75
Price After
$4.75
Q4 FY2025+0.00%
Report Date
Nov 6, 2025
EPS Beat/Miss
-97.0%
Price Before
$4.23
Price After
$4.23
Q3 FY2025+0.00%
Report Date
Jul 31, 2025
EPS Beat/Miss
+2.1%
Price Before
$4.23
Price After
$4.23
Q2 FY2025+0.00%
Report Date
Apr 23, 2025
EPS Beat/Miss
-9.3%
Price Before
$6.31
Price After
$6.31
Q1 FY2025+0.00%
Report Date
Feb 27, 2025
EPS Beat/Miss
+0.6%
Price Before
$6.31
Price After
$6.31
Q4 FY2024+0.00%
Report Date
Nov 7, 2024
EPS Beat/Miss
-12.3%
Price Before
$7.91
Price After
$7.91
Q3 FY2024+0.00%
Report Date
Aug 8, 2024
EPS Beat/Miss
+0.2%
Price Before
$6.40
Price After
$6.40
Avg Beat Reaction+0.00%
Avg Miss Reaction+0.00%
Beat Rate4 / 8 quarters
Largest Move+0.00% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BUGDF ends December
Bumrungrad Hospital Public Company Limited (BUGDF) most recently reported earnings on April 21, 2026 for Q2 FY2026, posting EPS of $0.06 — missing the analyst consensus of $0.06 by -1.1%. The next BUGDF earnings date is expected around September 1, 2026.
Each quarter, investors track BUGDF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BUGDF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BUGDF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BUGDF earnings · 5 questionsBumrungrad Hospital Public Company Limited's next earnings report is expected around September 1, 2026. BUGDF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BUGDF historically reports after market close (AMC).
BUGDF earnings datewhen is BUGDF earningsBUGDF next earnings datewhen does BUGDF report earningsBUGDF earnings calendar
▸ Source: FMP · Bumrungrad Hospital Public Company Limited SEC filings · US GAAP · Bumrungrad Hospital Public Company Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026